Therapeutic mAbs

Monoclonal antibodies development and applications. These therapeutic mAbs are characterized for binding monoespecifically to certain cells and proteins.

Therapeutic mAbs, Scientific Resources

Formats of Therapeutic Antibodies

The latest antibody engineering toolbox allows exploitation of the modular nature of antibodies to create a remarkable array of diverse and flexible formats of therapeutic antibodies. It is now possible to construct non-natural therapeutic antibodies with predetermined properties on a large scale.

Therapeutic mAbs

Antibody drug conjugates (ADC) for therapy

Delivering chemotherapy with the specificity of monoclonal antibodies!

Therapeutic mAbs, Analytics, News

Host Cell Protein analysis for biologics development

What are host cell proteins in biologic drugs?

News, Therapeutic mAbs

Critical Quality Attributes (CQAs) of Biologic Drugs

Defining critical quality attributes of biologics

Therapeutic mAbs, News, Scientific Resources

Therapeutic antibodies as Immune checkpoint inhibitors

Immunotherapy and Immune checkpoint inhibitors

Bispecific antibodies, Therapeutic mAbs

Bispecific Antibodies: Coming-of-age in Antibody Therapeutics (Part 2 of 2)

Bispecific Antibodies: Therapeutic applications and clinical pipeline. Bispecific antibodies have triggered considerable interest in the medical field and in the pharmaceutical industry over the last few years.

Therapeutic mAbs, Biosimilars

Therapeutic Antibodies to Treat Cancer Targeting CD20

Therapeutic antibodies for cancer targeting CD20 have been successfully used in immunotherapies to treat B-cell malignancies and auto-immune diseases.

Therapeutic mAbs, Biosimilars

Characterization of Therapeutic Monoclonal Antibodies

Characterization of therapeutic monoclonal antibodies are important to screen the right mAb molecule by defining the critical quality attributes.

Therapeutic mAbs, Biosimilars

Differences between Reference drugs (RMPs/RLDs) and Reference Standards

It is important to first establish a reference standard while assessing biosimilarity between a biosimilar product and the reference product.

Therapeutic mAbs

Monoclonal Antibody Therapy

Monoclonal antibody therapies have elevated precision medicine by enabling targeted therapy and providing personalized treatment options.